Trial Profile
A randomised, double blind, multi-centre, placebo controlled study to evaluate the efficacy and safety of methoxyflurane (Penthrox(TM)) for the treatment of acute pain in patients presenting to an Emergency Department with minor trauma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Methoxyflurane (Primary)
- Indications Acute pain; Musculoskeletal pain
- Focus Registrational; Therapeutic Use
- Acronyms STOP!
- Sponsors Medical Developments International
- 27 Aug 2016 Results of subgroup analysis (adult subgroup) published in the Advances in Therapy
- 17 Jun 2015 New source identified and integrated (ClinicalTrial.gov: US National Institutes of Health)
- 20 Oct 2012 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.